Gurnari C, Makishima H, Durmaz A, Attardi E, et al. DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study. Leukemia 2026;40:178-187.
PMID: 41339477